---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-039608"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2023-03-31T23:59:59+00:00"
generated_at: "2026-06-17T08:20:36.006931+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# P3 Health Partners Q4 2022 net loss $532.3M on $463.5M goodwill impairment; revenue up 40%

## Summary
- Q4 capitated revenue $254.0M (+40% YoY); net loss $532.3M vs $118.2M loss, primarily due to $463.5M goodwill impairment.
- Adjusted EBITDA loss $40.1M vs $35.6M; Adjusted EBITDA PMPM loss improved to $133 from $177 in Q4 2021.
- Full-year 2022 network contribution improved 65% vs 2021; company affirms 2023 guidance, expects Adjusted EBITDA positive in early 2024.
- Introduced year-end medical margin guidance as new non-GAAP metric.

## SEC filing metadata
- accession: 0001104659-23-039608
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2023-03-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000110465923039608/0001104659-23-039608-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000110465923039608/tm2311097d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-039608
- JSON: https://secwatch.observer/filing/0001104659-23-039608.json
- Plain text: https://secwatch.observer/filing/0001104659-23-039608.txt

## Key facts
- Earnings Releases
  P3 Health Partners Inc. updated its the fourth quarter and full year ended December 31, 2022 guidance (reaffirmed).
  - Period: the fourth quarter and full year ended December 31, 2022
  - Guidance: reaffirmed
  - Result: reported results
  source text: On March 31, 2023, P3 Health Partners Inc. (the “Company” or “P3”) announced its financial results for the three months and full year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832511/000110465923039608/0001104659-23-039608-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.